Quadrature Capital LTD Aurinia Pharmaceuticals Inc. Transaction History
Quadrature Capital LTD
- $8.45 Trillion
- Q3 2025
A detailed history of Quadrature Capital LTD transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 42,316 shares of AUPH stock, worth $649,550. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,316Holding current value
$649,550% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
269Shares Held
69.3MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...